BRIEF published on 06/18/2024 at 18:07, 5 months 4 days ago Funding Circle Plc: POS-Transaction in Own Shares London Stock Exchange Share Buyback Transaction Funding Circle Deutsche Numis
PRESS RELEASE published on 06/18/2024 at 18:02, 5 months 4 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces the purchase and cancellation of 200,000 ordinary shares. Details of transaction prices and volumes provided London Stock Exchange Ordinary Shares Share Buyback Cancellation Funding Circle Plc
BRIEF published on 06/17/2024 at 18:05, 5 months 5 days ago Funding Circle Plc Announces Buy-Back of Own Shares Share Buy-back London Stock Exchange Investor Relations Funding Circle Stock Repurchase
PRESS RELEASE published on 06/17/2024 at 18:00, 5 months 5 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 86,899 ordinary shares as part of its buy-back program on 17 June 2024 London Stock Exchange Ordinary Shares Buy-back Program Cancellation Funding Circle Plc
BRIEF published on 06/14/2024 at 18:13, 5 months 8 days ago Funding Circle Plc Executes Share Buyback of 175,000 Shares London Stock Exchange Share Buyback Financial Regulation Funding Circle Stock Repurchase
PRESS RELEASE published on 06/14/2024 at 18:08, 5 months 8 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase and cancellation of 175,000 ordinary shares at prices between 81.80p and 84.20p on the London Stock Exchange London Stock Exchange Share Purchase Cancellation Funding Circle Plc Buy-back
BRIEF published on 06/13/2024 at 18:09, 5 months 9 days ago Funding Circle Plc Announces Share Buyback Transaction London Stock Exchange Share Buyback Numis Securities Funding Circle 2024 Transactions
PRESS RELEASE published on 06/13/2024 at 18:04, 5 months 9 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc purchases 246,516 own shares for cancellation at prices ranging from 82.00p to 90.00p per share on the London Stock Exchange London Stock Exchange Share Buyback Own Shares Cancellation Funding Circle Plc
BRIEF published on 06/12/2024 at 17:55, 5 months 10 days ago Funding Circle Plc Executes Share Buy-Back Programme Share Buy-back London Stock Exchange Ordinary Shares Transaction Funding Circle
PRESS RELEASE published on 06/12/2024 at 17:50, 5 months 10 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc purchases 150,000 of its ordinary shares for cancellation at prices ranging from 88.00p to 90.00p per share, as part of its buy-back program London Stock Exchange Ordinary Shares Buy-back Program Funding Circle Plc Share Cancellation
Published on 11/22/2024 at 23:55, 5 hours 6 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 5 hours 31 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 5 hours 56 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 6 hours 31 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 10 hours 47 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 11 hours 8 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 12 hours 6 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 13 hours 1 minute ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 22 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 9 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 11 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 11 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
